Rebuilding pharma’s credibility in the age of misinformation
The episode of "The Top Line" features Dr. Freda Lewis-Hall discussing the fragile trust in the pharmaceutical industry amid rising misinformation. She emphasizes the importance of listening before messaging and explores how AI and omnichannel outreach can impact patient trust. Dr. Lewis-Hall advocates for rebuilding credibility through individual conversations, highlighting the need for industry-healthcare collaborations and the role of social media in restoring patient confidence.
Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious.
In this episode of "The Top Line," recorded at Fierce Pharma Week in Philadelphia, Freda Lewis-Hall, M.D., joins us to share how she has worked to put a human face on the industry. A psychiatrist, longtime patient advocate and former Pfizer chief medical officer, she explains why listening must come before messaging, how AI and omnichannel outreach can help or harm patient trust, and why rebuilding credibility starts one conversation at a time.
To learn more about the topics in this episode:
- TV ads close to overtaking doctors as consumers' primary source for learning about new meds: survey
- Pharma's reputation is stable-ish. Will that survive Trump 2.0?
- ABPI finds familiarity breeds trust, supporting push for industry-healthcare collaborations
- Doctor Mike calls on healthcare, pharma leaders to lean into social media to rebuild trust with patients
